Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care

Levy, M L; Stevenson, C; Maslen, T
November 1996
Thorax;Nov1996, Vol. 51 Issue 11, p1087
Academic Journal
No abstract available.


Related Articles

  • Immunosuppression in kids with asthma.  // Clinical Advisor;May2011, Vol. 14 Issue 5, p16 

    The article offers information on the administration of a five-day course of oral prednisolone for the treatment of asthma exacerbation among children.

  • Budesonide Inhalation Suspension: A Review of its Use in Infants, Children and Adults with Inflammatory Respiratory Disorders. Hvizdos, K.M.; Jarvis, B. // Drugs;Nov2000, Vol. 60 Issue 5, p1141 

    Budesonide, a topically active corticosteroid, has a broad spectrum of clinically significant local anti-inflammatory effects in patients with inflammatory lung diseases including persistent asthma. In infants and young children with persistent asthma, day- and night-time symptom scores, and the...

  • Fluticasone/salmeterol: better asthma outcomes at higher cost.  // PharmacoEconomics & Outcomes News;Feb2014, Vol. 696 Issue 1, p4 

    The article looks at the study "Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations" in the January 1, 2014 issue of the periodical "Allergy and Asthma Proceedings."

  • Single dose oral dexamethasone versus multi-dose prednisolone in the treatment of acute exacerbations of asthma in children who attend the emergency department: study protocol for a randomized controlled trial. Cronin, John; Kennedy, Una; McCoy, Siobhan; an Fhailí, Sinéad Nic; Crispino-O'Connel, Gloria; Hayden, John; Wakai, Abel; Walsh, Sean; O'Sullivan, Ronan // Trials;2012, Vol. 13 Issue 1, p141 

    Background: Asthma is a major cause of pediatric morbidity and mortality. In acute exacerbations of asthma, corticosteroids reduce relapses, subsequent hospital admission and the need for ß2-agonist therapy. Prednisolone is relatively short-acting with a half-life of 12 to 36 hours, thereby...

  • Comparison of Nebulised Budesonide and Prednisolone in Severe Asthma Exacerbation in Adults. Higenbottam, T.W.; Britton, J.; Lawrence, D.; Connolly, C.K.; Harrison, N.K.; Eastham, H.M.; Wilcock, C. // BioDrugs;2000, Vol. 14 Issue 4, p247 

    Background: Short courses of oral prednisolone are used as rescue therapy for severe asthma exacerbations. This study compares nebulised budesonide or oral prednisolone, both followed by budesonide Turbohaler®, as a treatment for severe asthma exacerbations, in the absence of life-threatening...

  • Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma. Lamb, H.M.; Culy, C.R.; Faulds, D. // PharmacoEconomics;2000, Vol. 18 Issue 5, p487 

    Unlabelled: Contemporary asthma management guidelines list inhaled corticosteroids as the preferred controller medication for patients with persistent asthma. Despite the availability of explicit guidelines, there is evidence that these agents are underused and that guidelines are...

  • Superiority of Oral Steroids in Acute Pediatric Asthma. Kirchner, Jeffrey T. // American Family Physician;3/15/2001, Vol. 63 Issue 6, p1203 

    Discusses a study by Schuh and others to compare the efficacy of inhaled fluticasone with oral prednisone in children with severe acute asthma. Description of the study and its results; Conclusion that oral prednisone is superior to inhaled fluticasone in the treatment of children with acute...

  • Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial. Busse, William; Wolfe, James; Storms, William; Srebro, Sharon; Edwards, Lisa; Johnson, Marty; Bowers, Brian W.; Rogenes, Paula R.; Rickard, Kathleen; Busse, W; Wolfe, J; Storms, W; Srebro, S; Edwards, L; Johnson, M; Bowers, B W; Rogenes, P R; Rickard, K // Journal of Family Practice;Jul2001, Vol. 50 Issue 7, p595 

    Objective: The objective of our study was to compare the efficacy and safety of fluticasone propionate (an inhaled corticosteroid) with zafirlukast (a leukotriene modifier) for persistent asthma.Study Design: In this randomized placebo-controlled, parallel-group,...

  • Asthma.  // Current Medical Literature: Respiratory Medicine;2008, Vol. 22 Issue 2, p41 

    The article presents abstracts on asthma which include the effect of an integrated care pathway on acute asthma/wheeze in children attending hospital, the limitations of intravenous magnesium sulphate in standard management in acute asthma, and the anti-inflammatory effects of high-dose inhaled...

  • Fluticasone Furoate/Vilanterol: a Review of Its Use in Patients with Asthma. Syed, Yahiya // Drugs;Mar2015, Vol. 75 Issue 4, p407 

    Fluticasone furoate/vilanterol (Relvar) is a once-daily, fixed combination of an inhaled corticosteroid (ICS) and a long-acting β-adrenoreceptor agonist (LABA), delivered via a dry powder inhaler (Ellipta). It is approved for the treatment of asthma in the EU and Japan, and is the first...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics